EDGAR database · Longevity Biotech
Longevity Biotech: 21 EDGAR entities
Every enriched entity AltStreet tracks on longevity biotech platforms: $780M reported sold across 21 vehicles, 370 investor slots in the latest notices, from 21 platforms. Each row opens the entity's page with its filings, the economics it reported and the people it named. Ordered by reported amount sold.
What longevity biotech is and how it is sold: the Longevity Biotech category page. Issuers by industry and month: the issuer directory.
By platform
Entities
| Entity | Type | Raised | Investors | Year | Exemption |
|---|---|---|---|---|---|
| Decheng Capital Global Life Sciences Fund V, L.P. Decheng Capital Global Life Sciences Fund V, L.P. | Fund | $452M | 42 | 2025 | 506(b), 3(c)(1) |
| Special Situations Life Sciences Fund LP Special Situations Life Sciences Fund LP | Fund | $75M | 112 | 2025 | 506(b), 3(c)(1) |
| Sky Life Sciences Fund, LP Sky Life Sciences Fund, LP | Fund | $62M | 10 | 2026 | 506(b), 3(c)(1) |
| CCA Longevity Fund III (US), LLC CCA Longevity Fund III (US), LLC | Fund | $55M | 51 | 2023 | 506(b), 3(c) |
| CCA LONGEVITY FUND IV (US II), LLC CCA LONGEVITY FUND IV (US II), LLC | Fund | $48M | 90 | 2023 | 506(b), 3(c) |
| Driehaus Life Sciences Fund, Ltd. Driehaus Life Sciences Fund, Ltd. | Fund | $28M | 12 | 2026 | 506(b), 3(c)(1) |
| CCA Longevity Fund IV (US III), LLC CCA Longevity Fund IV (US III), LLC | Fund | $28M | 8 | 2023 | 506(b), 3(c) |
| Echo Life Sciences Fund, LP Echo Life Sciences Fund, LP | Fund | $12M | 9 | 2023 | 506(b), 3(c)(1) |
| Ishara Biotech Fund LP Ishara Biotech Fund LP | Fund | $8M | 11 | 2026 | 506(b), 3(c)(1) |
| Cultivation Capital Life Sciences Fund IV, LP Cultivation Capital Life Sciences Fund IV, LP | Fund | $7M | N/D | 2026 | 506(b), 3(c)(1) |
| R42 Al & LONGEVITY FUND 3-1 LP R42 Al & LONGEVITY FUND 3-1 LP | Fund | $4M | 8 | 2023 | 506(b), 3(c)(1) |
| WDC Biotech Fund I, LLC WDC Biotech Fund I, LLC | Fund | $450K | 17 | 2024 | 506(b), 3(c)(1) |
| Verdad Biotech Fund, L.P. Verdad Biotech Fund, L.P. | Fund | · | N/D | 2026 | 506(b), 506(c), Rule 504, 4(a)(5) |
| Analytical Biotech Fund, LP Analytical Biotech Fund, LP | Fund | · | N/D | 2026 | 506(b), 3(c)(1) |
| CCA Longevity Fund V (US) LLC CCA Longevity Fund V (US) LLC | Fund | · | N/D | 2024 | 506(b), 3(c) |
| GLACIER BASIN BIOTECH FUND LLC GLACIER BASIN BIOTECH FUND LLC | Fund | · | N/D | 2023 | 506(b), 3(c)(1) |
| RiverRock Longevity Fund I LP RiverRock Longevity Fund I LP | Fund | · | N/D | 2023 | 506(b), 3(c)(1) |
| Tridge Life Sciences Fund, LP Tridge Life Sciences Fund, LP | Fund | · | N/D | 2026 | 506(b), 3(c)(1) |
| CCA Longevity Fund V (US III), LLC CCA Longevity Fund V (US III), LLC | Fund | · | N/D | 2024 | 506(b), 3(c) |
| Bain Capital Life Sciences Fund IV, L.P. Bain Capital Life Sciences Fund IV, L.P. | Fund | · | N/D | 2024 | 506(b), 3(c) |
| Setara Life Sciences Fund LP Setara Life Sciences Fund LP | Fund | · | N/D | 2026 | 506(b), 3(c)(1) |